[go: up one dir, main page]

WO2010049011A3 - Combinaison de substances actives pour le traitement d'une peau mature ii - Google Patents

Combinaison de substances actives pour le traitement d'une peau mature ii Download PDF

Info

Publication number
WO2010049011A3
WO2010049011A3 PCT/EP2008/067766 EP2008067766W WO2010049011A3 WO 2010049011 A3 WO2010049011 A3 WO 2010049011A3 EP 2008067766 W EP2008067766 W EP 2008067766W WO 2010049011 A3 WO2010049011 A3 WO 2010049011A3
Authority
WO
WIPO (PCT)
Prior art keywords
dalton
skin
hyaluronic acid
active
silanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2008/067766
Other languages
German (de)
English (en)
Other versions
WO2010049011A2 (fr
Inventor
Iris Marina Stadler
Annika Bähren
Alexandra Struwe
Marianne Waldmann-Laue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Priority to RU2011121874/15A priority Critical patent/RU2011121874A/ru
Priority to EP08875470A priority patent/EP2451434A2/fr
Publication of WO2010049011A2 publication Critical patent/WO2010049011A2/fr
Anticipated expiration legal-status Critical
Publication of WO2010049011A3 publication Critical patent/WO2010049011A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention porte sur des compositions topiques cosmétiques ou dermatologiques pour le traitement d'une peau mature ou intrinsèquement ou extrinsèquement âgée, en particulier pour le traitement antirides, qui comprennent, dans un support cosmétique ou dermatologique approprié, une combinaison d'au moins un hydrolysat de protéine de soja avec une masse moléculaire moyenne dans la plage de 600-1 000 daltons, de préférence 800 daltons, au moins un extrait hydrophile de graines d'ambrette, au moins une substance active, choisie parmi l'acide hyaluronique, les éthers de silanol, les esters de silanol et les sels de l'acide hyaluronique, et au moins un di-, tri-, tétra-, penta- ou hexapeptide, qui peut être N-acylé et/ou estérifié et/ou exister en tant que sel physiologiquement acceptable et qui stimule dans la peau la libération de facteurs de croissance comme par exemple le TGF et ensuite stimule la synthèse de collagène et/ou de fibronectine.
PCT/EP2008/067766 2008-10-31 2008-12-17 Combinaison de substances actives pour le traitement d'une peau mature ii Ceased WO2010049011A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
RU2011121874/15A RU2011121874A (ru) 2008-10-31 2008-12-17 Комбинация биологически активных веществ для обработки зрелой кожи ii
EP08875470A EP2451434A2 (fr) 2008-10-31 2008-12-17 Combinaison de substances actives pour le traitement d'une peau mature ii

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008054117.6 2008-10-31
DE102008054117A DE102008054117A1 (de) 2008-10-31 2008-10-31 Wirkstoffkombination zur Behandlung reifer Haut II

Publications (2)

Publication Number Publication Date
WO2010049011A2 WO2010049011A2 (fr) 2010-05-06
WO2010049011A3 true WO2010049011A3 (fr) 2012-06-07

Family

ID=42062976

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/067766 Ceased WO2010049011A2 (fr) 2008-10-31 2008-12-17 Combinaison de substances actives pour le traitement d'une peau mature ii

Country Status (4)

Country Link
EP (1) EP2451434A2 (fr)
DE (1) DE102008054117A1 (fr)
RU (1) RU2011121874A (fr)
WO (1) WO2010049011A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016520069A (ja) * 2013-05-10 2016-07-11 サザン・リサーチ・インスティテュート ＴＧＦ‐β活性阻害を介した疾患の治療のための化合物、組成物及び方法
WO2017013172A1 (fr) * 2015-07-23 2017-01-26 Stichting Katholieke Universiteit Nouveaux inhibiteurs de la glycoprotéine p
CA3013459C (fr) 2016-02-04 2020-12-29 ALASTIN Skincare, Inc. Compositions topiques comprenant du tripeptide-1 et de l'hexapeptide-12
CN111182914A (zh) 2017-08-03 2020-05-19 阿拉斯廷护肤公司 用于改善皮肤松弛和身体轮廓的组合物和方法
WO2019060357A1 (fr) * 2017-09-21 2019-03-28 Muhammed Majeed Procédé de préparation de tripeptide contenant de l'acide oléanolique et applications thérapeutiques associées
WO2020028694A1 (fr) 2018-08-02 2020-02-06 ALASTIN Skincare, Inc. Compositions liposomales et procédés d'utilisation
DE102019218242A1 (de) * 2019-11-26 2021-05-27 Beiersdorf Ag Wirkstoffkombinationen aus Ubichinol und Hyaluronsäure und kosmetische oder dermatologische Zubereitungen, solche Wirkstoffkombinationen enthaltend
CN111759748B (zh) * 2020-08-14 2023-04-11 广州市乾相生物科技有限公司 一种抗衰老肽类组合物及其应用
CN116327636B (zh) * 2023-03-06 2024-06-25 山东福瑞达生物股份有限公司 一种保湿修护组合物及其应用、制备方法
EP4647063A1 (fr) * 2024-05-07 2025-11-12 Etichub S.r.l. Procédé cosmétique pour l'optimisation de paramètres esthétiques de la peau et des appendices de la peau

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1640041A2 (fr) * 2004-09-24 2006-03-29 Henkel Kommanditgesellschaft auf Aktien composition cosmétique ou dermatologique pour le traitement du vieillissement de la peau ou pour le traitement de la peau endommagée par la lumière
WO2006080768A1 (fr) * 2005-01-31 2006-08-03 Amorepacific Corporation Composition cosmétique anti-vieillissement
US20060198800A1 (en) * 2003-08-14 2006-09-07 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
EP1790330A2 (fr) * 2005-10-14 2007-05-30 Henkel Kommanditgesellschaft auf Aktien Compositions cosmétiques et dermatologiques comprenant des oligopeptides et un extrait de pommes
EP1815843A2 (fr) * 2005-12-29 2007-08-08 Henkel KGaA Combinaisons synergétiques d'hydrolysats de protéines destinées au traitement des peaux mûres
WO2008029064A2 (fr) * 2006-09-06 2008-03-13 Thorel Jean-Noel Utilisation topique d'un extrait peptidique de soja et/ou de ble comme agent photoprotecteur
DE102007024679A1 (de) * 2006-10-17 2008-07-10 Engelhard Lyon S.A. Verwendung von kosmetisch aktiven Wirkstoffen zum Schützen von FGF-2
WO2009121422A1 (fr) * 2008-04-02 2009-10-08 Basf Beauty Care Solutions France Sas Principe actif qui stimule la prolifération et/ou l'activité des fibroblastes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10163246A1 (de) 2001-12-21 2003-07-10 Henkel Kgaa Neue Verwendung von Apfelkernextrakten in kosmetischen oder pharmazeutischen Zusammensetzung

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060198800A1 (en) * 2003-08-14 2006-09-07 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
EP1640041A2 (fr) * 2004-09-24 2006-03-29 Henkel Kommanditgesellschaft auf Aktien composition cosmétique ou dermatologique pour le traitement du vieillissement de la peau ou pour le traitement de la peau endommagée par la lumière
WO2006080768A1 (fr) * 2005-01-31 2006-08-03 Amorepacific Corporation Composition cosmétique anti-vieillissement
EP1790330A2 (fr) * 2005-10-14 2007-05-30 Henkel Kommanditgesellschaft auf Aktien Compositions cosmétiques et dermatologiques comprenant des oligopeptides et un extrait de pommes
EP1815843A2 (fr) * 2005-12-29 2007-08-08 Henkel KGaA Combinaisons synergétiques d'hydrolysats de protéines destinées au traitement des peaux mûres
WO2008029064A2 (fr) * 2006-09-06 2008-03-13 Thorel Jean-Noel Utilisation topique d'un extrait peptidique de soja et/ou de ble comme agent photoprotecteur
DE102007024679A1 (de) * 2006-10-17 2008-07-10 Engelhard Lyon S.A. Verwendung von kosmetisch aktiven Wirkstoffen zum Schützen von FGF-2
WO2009121422A1 (fr) * 2008-04-02 2009-10-08 Basf Beauty Care Solutions France Sas Principe actif qui stimule la prolifération et/ou l'activité des fibroblastes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Pentapharm Syn-Coll", 4 November 2008 (2008-11-04), pages 1 - 4, XP002502708, Retrieved from the Internet <URL:http://web.archive.org/web/20070306175636/http://www.ingredientstodie for.com/files/DATA_Syn-Coll.pdf> [retrieved on 20081104] *

Also Published As

Publication number Publication date
RU2011121874A (ru) 2012-12-10
EP2451434A2 (fr) 2012-05-16
DE102008054117A1 (de) 2010-05-06
WO2010049011A2 (fr) 2010-05-06

Similar Documents

Publication Publication Date Title
WO2010049011A3 (fr) Combinaison de substances actives pour le traitement d&#39;une peau mature ii
KR101686399B1 (ko) 항노화용 화장료 조성물
US20070207180A1 (en) Synthetic polypeptide-containing bioapplicable material and film-forming material
CN111182914A (zh) 用于改善皮肤松弛和身体轮廓的组合物和方法
US20130295122A1 (en) Elastin digest compositions and methods utilizing same
KR101978095B1 (ko) 벌꿀과 펩티드의 조합을 포함하는 화장품 또는 피부병치료 조성물
WO2009136291A3 (fr) Extraits cellulaires
JP6430109B2 (ja) 外用組成物
EP2656832A3 (fr) Administration de cellules et d&#39;extraits cellulaires pour le rajeunissement
AU2008243084B2 (en) Synthetic peptides used for treating the skin and use thereof in cosmetic or dermopharmaceutical compositions
CN109152727B (zh) 可可豆的肽和糖水解产物、含有其的化妆品组合物以及该化妆品组合物的化妆品用途
ES2769268T3 (es) Extracto sinérgico de Palmaria palmata
WO2010049457A3 (fr) Combinaison de principes actifs pour le traitement des peaux matures
US20200354431A1 (en) Mutable collagenous tissue from echinoderms
GB2543822A (en) Skin care composition and method thereof
JP2016501866A5 (fr)
US20230148647A1 (en) Composition for promoting biosynthesis of elastin and collagen in connective tissue
WO2009138801A2 (fr) Formulation cosmétique
JP6153469B2 (ja) ダイズタンパク質の加水分解物を含有する組成物
WO2010146078A3 (fr) Nouvelles utilisations de compositions d&#39;hydroxyproline
Bojarska Amino acids and short peptides as anti-aging “Superfood”
WO2011051457A3 (fr) Composition de protéine emd purifiée
KR20220030151A (ko) 연결 조직 중 엘라스틴 및 콜라겐 생합성 증진용 조성물
WO2010119997A1 (fr) Peptide ayant une activite de facteur de croissance de transformation-beta et son procede de production
US20160243021A1 (en) Collagen-Boosting Compositions And Methods

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2008875470

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2008875470

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2011121874

Country of ref document: RU